ABIN2839514
antibody from antibodies-online
Targeting: EGR1
AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2839514 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Early Growth Response 1 (EGR1) (AA 9-37), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 9-37, N-Term
- Antibody clone number
- RB19179
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression.
High-level expression of early growth response-1 and association of polymorphism with total IgE and atopy in allergic rhinitis adults.
Zhang H, Chen X, Wang J, Guang W, Han W, Zhang H, Tan X, Gu Y
Scientific reports 2014 Jul 3;4:5416
Scientific reports 2014 Jul 3;4:5416
High-level expression of early growth response-1 and association of polymorphism with total IgE and atopy in allergic rhinitis adults.
Chan IH, Lee DL, Ho OY, Wong EW, Lam YY, Tang NL, Chan MH, Abdullah VJ, Wong CK, Lam CW
Clinica chimica acta; international journal of clinical chemistry 2010 Jan;411(1-2):67-71
Clinica chimica acta; international journal of clinical chemistry 2010 Jan;411(1-2):67-71
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS